French Other Utilities Stock News

ENXTPA:EXENS
ENXTPA:EXENSAerospace & Defense

A Look At Exosens (ENXTPA:EXENS) Valuation After A Strong Year Of Shareholder Returns

What the recent price move says about Exosens Exosens (ENXTPA:EXENS) has caught investor attention after a recent share price move, with the stock closing at €65.20 and short term returns over the past week, month, and past 3 months standing in positive territory. See our latest analysis for Exosens. Beyond the recent jump, Exosens has combined strong short term share price momentum with a very large 1 year total shareholder return of 104.23%, which suggests shifting expectations around its...
ENXTPA:IVA
ENXTPA:IVABiotechs

A Look At Inventiva (ENXTPA:IVA) Valuation As NATiV3 Enrollment Completes And Odiparcil Rights Are Sold

Inventiva (ENXTPA:IVA) is back on investors’ radars after completing enrollment in its global Phase III NATiV3 trial for lanifibranor in MASH, while selling odiparcil rights to focus resources and potential future milestone income. See our latest analysis for Inventiva. At a share price of €4.72, the stock has a 90 day share price return of 19.8% and a 1 year total shareholder return of 82.95%, suggesting momentum has been building as investors focus on the NATiV3 progress and portfolio...
ENXTPA:OR
ENXTPA:ORPersonal Products

L'Oréal’s €4b Kering Beauté Deal Deepens Luxury And Wellness Story

L'Oréal (ENXTPA:OR) has completed a €4b acquisition of Kering Beauté. The deal includes exclusive beauty rights for Creed, Balenciaga, and Bottega Veneta. The company and Kering have formalized a long-term partnership focused on luxury, wellness, and longevity. L'Oréal, a global beauty group with a wide portfolio spanning mass, premium, and luxury brands, is adding more depth to its high end offering with Kering Beauté. For readers tracking the luxury segment, this deal sits at the...
ENXTPA:VK
ENXTPA:VKEnergy Services

Assessing Vallourec (ENXTPA:VK) Valuation After New Offshore Pipe Contracts In Indonesia

Contract wins in Indonesia set the context Vallourec (ENXTPA:VK) recently reported a series of five contracts in Indonesia for about 36,000 tons of premium pipes and connections, supplying complex offshore oil and gas projects across roughly 140 wells. See our latest analysis for Vallourec. These Indonesia contract wins come as the share price trades at €22.04, with a 15.42% 1 month share price return and a 37.75% year to date share price return, alongside a 61.15% 1 year total shareholder...
ENXTPA:MC
ENXTPA:MCLuxury

Is It Time To Revisit LVMH Moët Hennessy Louis Vuitton Société Européenne ENXTPA MC After Share Slide

Wondering whether LVMH Moët Hennessy - Louis Vuitton Société Européenne is starting to look attractively priced? This article focuses squarely on what you are getting for the price you pay. The stock last closed at €471.05, with a 3.4% return over 7 days, a 6.9% decline over 30 days, and year-to-date and 1-year returns of 26.6% and 9.0% declines, alongside a 39.8% decline over 3 years and a 12.6% decline over 5 years. Recent coverage around LVMH Moët Hennessy - Louis Vuitton Société...
ENXTPA:ML
ENXTPA:MLAuto Components

A Look At Michelin’s (ENXTPA:ML) Valuation As Shares Trade Below Popular Fair Value Estimates

Recent Share Performance and Business Snapshot Compagnie Générale des Établissements Michelin Société en commandite par actions (ENXTPA:ML) has seen a mix of short term moves, with a 1 day return of about a 1% decline, contrasting with gains over the past week and the past 3 months. Over the past month the stock shows a return of about a 5% decline, while year to date performance is positive. The current share price of €29.69 sits alongside a market value of about €20.4b. Michelin reports...
ENXTPA:AMUN
ENXTPA:AMUNCapital Markets

Fresh Look At Amundi (ENXTPA:AMUN) Valuation After Recent Performance Shifts

Fresh look at Amundi after recent performance shifts Amundi (ENXTPA:AMUN) is back on investor radars after mixed recent returns, with a 1 day decline, a small gain over the past week, and a slight drop over the past month. See our latest analysis for Amundi. With the share price at €74.1, Amundi’s recent setbacks over the past day and month contrast with a positive 90 day share price return of 4.07% and a stronger one year total shareholder return of 25.55%. This suggests earlier momentum has...
ENXTPA:AKE
ENXTPA:AKEChemicals

Assessing Arkema (ENXTPA:AKE) Valuation After Recent Share Price Momentum Shifts

Event overview and recent share performance Arkema (ENXTPA:AKE) shares recently closed at €58.10 after a mixed stretch, with a small 1 day decline, a broadly flat week, and positive moves over the past month and past 3 months. Over longer horizons the picture is different. The stock has shown a 3% decline over the past year and deeper negative total returns over the past 3 and 5 years, which may catch the eye of value focused investors. See our latest analysis for Arkema. For Arkema, the...
ENXTPA:EL
ENXTPA:ELMedical Equipment

Assessing EssilorLuxottica (ENXTPA:EL) Valuation After Ray Ban Meta Smart Glasses Expansion

EssilorLuxottica Société anonyme (ENXTPA:EL) is drawing attention after expanding its Ray-Ban Meta AI glasses portfolio with prescription friendly, optical first designs and broader international distribution, which links eyewear more tightly with everyday digital services. See our latest analysis for EssilorLuxottica Société anonyme. The Ray-Ban Meta news and EssilorLuxottica’s recent deal in Thailand arrive while the share price has seen a 30 day share price return of an 11.42% decline and...
ENXTPA:NANO
ENXTPA:NANOBiotechs

Is It Too Late To Consider Nanobiotix (ENXTPA:NANO) After Its 7x One Year Surge?

If you are wondering whether Nanobiotix is priced attractively or already running ahead of itself, the recent share performance raises some important valuation questions. The stock last closed at €27.40, with a 3.4% gain over 7 days, a 5.0% decline over 30 days, a 44.2% return year to date, and a very large 1-year return of more than 7x. These moves have kept Nanobiotix on many investors' watchlists, supported by ongoing attention on its cancer treatment technologies and partnerships in the...
ENXTPA:EXENS
ENXTPA:EXENSAerospace & Defense

Exosens Record Defense Order Spurs Questions On Undervalued Shares

Exosens (ENXTPA:EXENS) secured a record order for its ultra compact thermal camera cores. The order comes from a major European developer of autonomous air defense systems. The thermal camera cores are intended for use in drone and counter drone applications across unmanned platforms. Exosens focuses on advanced digital imaging technologies that serve defense and security customers, with thermal imaging as a core capability. This record order reflects interest in compact, high performance...
ENXTPA:TTE
ENXTPA:TTEOil and Gas

TotalEnergies Trading Windfall And North Sea Merger Reframe Valuation Case

TotalEnergies generated more than €1b in trading profits during recent Middle East supply disruptions, helped by heavy buying of UAE and Omani cargoes and risk hedging activity. The company has completed the merger of its UK North Sea business with NEO NEXT, forming NEO NEXT+ as the region’s largest independent oil and gas producer. TotalEnergies (ENXTPA:TTE) is coming off a strong share price run, with the stock at €79.42 and up 18.9% over the past month, 41.6% year to date and 58.6% over...
ENXTPA:PLNW
ENXTPA:PLNWSoftware

Assessing Planisware SAS (ENXTPA:PLNW) Valuation After Recent Share Price Weakness

What Recent Returns Say About Planisware SAS Planisware SAS (ENXTPA:PLNW) has caught investor attention after a period of weak share performance, with the stock showing a 7.5% decline over the past month and a 37% decline over the past 3 months. See our latest analysis for Planisware SAS. While the recent 30 day share price return of a 7.5% decline and 90 day share price return of a 37% decline point to fading momentum, the latest €14.58 share price and 1 year total shareholder return of a...
ENXTPA:GET
ENXTPA:GETInfrastructure

Assessing Getlink (ENXTPA:GET) Valuation After A Strong Recent Share Price Run

Why Getlink stock is on investors’ radar Getlink (ENXTPA:GET) has recently drawn attention after a solid run in its shares over the past month and past 3 months, prompting investors to reassess how its core tunnel and rail operations are valued. See our latest analysis for Getlink. The recent move to a €19.37 share price comes after a 21.75% year to date share price return and a 23.03% total shareholder return over 12 months, which points to building momentum rather than a one off move. If...
ENXTPA:AI
ENXTPA:AIChemicals

A Look At Air Liquide (ENXTPA:AI) Valuation After New Taiwan Semiconductor Materials Plant Opening

L'Air Liquide (ENXTPA:AI) has attracted fresh attention after unveiling a new Advanced Materials manufacturing plant in Taichung City, Taiwan, focused on deposition and etching materials for regional semiconductor customers. See our latest analysis for L'Air Liquide. The new Taiwan facility comes at a time when the share price has shown firm momentum, with a 7 day share price return of 5.37% and a 90 day share price return of 13.53%. Meanwhile, the 5 year total shareholder return of 70.44%...
ENXTPA:DBV
ENXTPA:DBVBiotechs

DBV Technologies Nears Viaskin Peanut Resubmission As Funding Risks Linger

DBV Technologies plans to resubmit its Biologics License Application to the FDA for the Viaskin Peanut Patch for children after addressing earlier regulatory concerns. The resubmission follows positive Phase 3 VITESSE trial results and a strengthened financial position. Regulatory clearance for Viaskin Peanut could open a path to commercializing the patch in the pediatric peanut allergy market. For investors tracking ENXTPA:DBV, the planned BLA resubmission comes at a time when the share...
ENXTPA:DSY
ENXTPA:DSYSoftware

Dassault Systèmes (ENXTPA:DSY) Margin Holding Near 19% Tests Bullish Expansion Narrative

Dassault Systèmes (ENXTPA:DSY) closed out FY 2025 with fourth quarter revenue of €1.7b and basic EPS of €0.33, while trailing twelve month figures sat at €6.2b in revenue and EPS of €0.91. Over the past year, revenue has moved in a tight range around the €6.2b level and EPS has hovered close to €0.91 on a trailing basis. This provides a consistent read on the earnings power behind the current €17.62 share price, with margins holding around the high teens. See our full analysis for Dassault...
ENXTPA:PUB
ENXTPA:PUBMedia

Is Publicis Groupe (ENXTPA:PUB) Price Weakness Creating An Opportunity For Long-Term Investors

Wondering if Publicis Groupe at €72.48 is a bargain or a value trap? This article breaks down what the current price might be saying about the stock. The share price has returned 4.1% over the last 7 days, while the 1 month return is a 1.3% decline and the year to date return stands at a 17.3% decline, with a 1 year return of an 11.0% decline and a longer term 5 year return of 70.5%. Recent coverage around Publicis Groupe has focused on how the stock's pullback this year compares with its...
ENXTPA:CS
ENXTPA:CSInsurance

European Dividend Stocks To Consider In April 2026

As European markets experience a wave of optimism, with the STOXX Europe 600 Index rising by 3.92% amid hopes for a short-lived Middle East conflict, investors are keenly observing how inflation and energy costs impact economic forecasts across the region. In this environment, dividend stocks can offer stability and income potential, making them an attractive consideration for those looking to navigate market volatility while benefiting from steady returns.
ENXTPA:ACA
ENXTPA:ACABanks

Crédit Agricole (ENXTPA:ACA) Valuation Check As Shares Sit Below Narrative Fair Value

How Crédit Agricole’s recent share performance frames today’s discussion Crédit Agricole (ENXTPA:ACA) has given investors a mixed ride recently, with the share price down about 1.3% over the past day, up over the past week, but weaker over the past month and past 3 months. Against that backdrop, the bank’s longer term total returns and current financial profile, including €26,557m in revenue and €6,598m in net income, provide additional context for evaluating whether the current share price...